| 000 | 01489 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516135356.0 | ||
| 264 | 0 | _c20130523 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm301280p _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdul-Hay, Samer O | |
| 245 | 0 | 0 |
_aOptimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMar 2013 |
||
| 300 |
_a2246-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xchemical synthesis |
| 650 | 0 | 4 |
_aInsulysin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aLane, Amy L | |
| 700 | 1 | _aCaulfield, Thomas R | |
| 700 | 1 | _aClaussin, Clémence | |
| 700 | 1 | _aBertrand, Juliette | |
| 700 | 1 | _aMasson, Amandine | |
| 700 | 1 | _aChoudhry, Shakeel | |
| 700 | 1 | _aFauq, Abdul H | |
| 700 | 1 | _aMaharvi, Guhlam M | |
| 700 | 1 | _aLeissring, Malcolm A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 56 _gno. 6 _gp. 2246-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm301280p _zAvailable from publisher's website |
| 999 |
_c22531441 _d22531441 |
||